Aortic Valve Insufficiency
FDA Introduces New Guidance on AI for Drug Approval Submissions in 2025
FDA, AI, drug approval, guidance, regulatory decision-making, medical devices, artificial intelligence, drug development
Carecode Revolutionizes Brazilian Healthcare with AI-Powered Customer Service, Secures $4.3M Funding
Carecode, AI, Healthcare, Customer Service, Automation, Funding, Brazilian Healthcare
GSK and Relation Therapeutics Collaborate on Fibrosis and Osteoarthritis Research with AI-Driven Approach
Relation Therapeutics, GSK, Fibrosis, Osteoarthritis, AI in drug discovery, Machine learning in biotech
Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology
Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation
Cleerly Secures $192M for Heart Attack-Predicting AI Technology
Cleerly, AI, Heart Disease, Coronary Artery Scanning, Funding
Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry
AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements
Iambic Therapeutics Enhances AI Suite with “Enchant” for Predictive Preclinical Drug Development
Iambic Therapeutics, AI, Enchant, preclinical predictive powers, drug discovery, clinical success prediction
FogPharma Rebrands to Parabilis Medicines, Emphasizing AI-Driven Drug Discovery
FogPharma, Parabilis Medicines, AI capabilities, drug discovery, rebranding
Amazon One Medical Introduces AI Tools to Enhance Primary Care Experience
Amazon One Medical, AI tools, primary care, healthcare technology, generative AI, patient care, administrative workload
Revolutionizing Talent Acquisition: The Future Impact of AI
AI in Talent Acquisition, Future of Recruitment, AI-Powered Recruiting Tools, Efficiency and Personalization, Challenges and Ethical Considerations